QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.

scientific article

QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1517/17460441.2015.968123
P698PubMed publication ID25297377

P50authorJuan C Garro MartinezQ83313101
P2093author name stringEsteban G Vega-Hissi
Mario R Estrada
Matías F Andrada
P2860cites workDevelopment of the Colle-Salvetti correlation-energy formula into a functional of the electron densityQ21708802
Synthesis and anticonvulsant activities of N-benzyl (2R)-2-acetamido-3-oxysubstituted propionamide derivativesQ24657737
Density-functional thermochemistry. III. The role of exact exchangeQ25938987
van der Waals Volumes and RadiiQ26778457
Distinguishing Atom Differences in a Molecular Graph Shape IndexQ28842837
Shape Indexes of Orders One and Three from Molecular GraphsQ28842843
UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulationsQ29038555
Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-173.Q33182400
Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonistsQ33196254
Synthesis and anticonvulsant activities of (R)-N-(4'-substituted)benzyl 2-acetamido-3-methoxypropionamidesQ33640451
On the topological sub-structural molecular design (TOSS-MODE) in QSPR/QSAR and drug design researchQ33893519
Enaminones 8: CoMFA and CoMSIA studies on some anticonvulsant enaminonesQ34558460
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary resultsQ34584338
QSAR study and molecular design of open-chain enaminones as anticonvulsant agentsQ35669566
A novel automated lazy learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL-QSAR modelsQ36876902
Characterization of the anticonvulsant profile of valpromide derivativesQ38517170
Epilepsy care: image of the futureQ41001699
Synthesis and structure-activity studies of alkyl-substituted .gamma.-butyrolactones and .gamma.-thiobutyrolactones: ligands for the picrotoxin receptorQ41155324
Review, reevaluation, and new results in quantitative structure-activity studies of anticonvulsantsQ41726352
Anticonvulsant enaminones depress excitatory synaptic transmission in the rat brain by enhancing extracellular GABA levelsQ41830219
Comparative Molecular Similarity Indices Analysis of 1-(Naphthylalky1)-1H-imidazole Analogs with Antiepileptic ActivityQ42077853
Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effectQ42553750
Alpha-spirocyclopentyl- and alpha-spirocyclopropyl-gamma-butyrolactones: conformationally constrained derivatives of anticonvulsant and convulsant alpha,alpha-disubstituted gamma-butyrolactonesQ42612071
Design, synthesis and biological evaluation of some novel benzimidazole derivatives for their potential anticonvulsant activityQ42956958
3D-QSAR studies on a series of 5-arylidine-2, 4-thiazolidinediones as aldose reductase inhibitors: a self-organizing molecular field analysis approachQ43093886
Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazoleQ43255677
QSAR Studies on antiepileptic and locomotor in vivo activities of 4,5-diphenyl-1H-imidazoles.Q43555847
Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxinQ43719781
Do structural properties explain the anticonvulsant activity of valproate metabolites? A QSAR analysisQ44004462
N-Substituted 4-amino-3,3-dipropyl-2(3H)-furanones: new positive allosteric modulators of the GABA(A) receptor sharing electrophysiological properties with the anticonvulsant loreclezoleQ44025551
Synthesis and anticonvulsant activity of enaminones. Part 7. Synthesis and anticonvulsant evaluation of ethyl 4-[(substituted phenyl)amino]-6-methyl-2-oxocyclohex-3-ene-1-carboxylates and their corresponding 5-methylcyclohex-2-enone derivativesQ44320480
Development of quantitative structure-activity relationships and classification models for anticonvulsant activity of hydantoin analoguesQ44454069
N-Substituted amino acid N'-benzylamides: synthesis, anticonvulsant, and metabolic activitiesQ44895473
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonistsQ45713595
Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compoundsQ46741550
Enaminones 9. Further studies on the anticonvulsant activity and potential type IV phosphodiesterase inhibitory activity of substituted vinylic benzamidesQ46747817
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptorQ47933771
Anticonvulsant activity and interactions with neuronal voltage-dependent sodium channel of analogues of ameltolide.Q48404545
Structure-activity studies of fluoroalkyl-substituted gamma-butyrolactone and gamma-thiobutyrolactone modulators of GABA(A) receptor functionQ48510584
Anticonvulsant evaluation and mechanism of action of benzylamino enaminonesQ48580345
CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsQ53340989
Synthesis and antiepileptic studies of new imidazo[1,2-a]pyridine derivativesQ57714469
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)37-51
P577publication date2014-10-09
P1433published inExpert Opinion on Drug DiscoveryQ5421204
P1476titleQSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity
P478volume10